392 related articles for article (PubMed ID: 3543453)
21. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
22. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
24. Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies.
Ishii Y; Takami T; Yuasa H; Takei T; Kikuchi K
Clin Exp Immunol; 1984 Oct; 58(1):183-92. PubMed ID: 6332692
[TBL] [Abstract][Full Text] [Related]
25. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
[TBL] [Abstract][Full Text] [Related]
26. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB
J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627
[TBL] [Abstract][Full Text] [Related]
27. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
[TBL] [Abstract][Full Text] [Related]
29. Two surface antigens expressed on proliferating mouse T lymphocytes defined by rat monoclonal antibodies.
Takei F
J Immunol; 1983 Jun; 130(6):2794-7. PubMed ID: 6304191
[TBL] [Abstract][Full Text] [Related]
30. Identification of an early activation antigen (Bac-1) on human B cells.
Suzuki T; Sanders SK; Butler JL; Gartland GL; Komiyama K; Cooper MD
J Immunol; 1986 Aug; 137(4):1208-13. PubMed ID: 3090143
[TBL] [Abstract][Full Text] [Related]
31. Human monoclonal antibodies reactive with human myelomonocytic leukemia cells.
Posner MR; Santos DJ; Elboim HS; Tumber MB; Frackelton AR
Cancer Res; 1989 Apr; 49(7):1665-70. PubMed ID: 2924315
[TBL] [Abstract][Full Text] [Related]
32. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.
Gougos A; Letarte M
J Immunol; 1988 Sep; 141(6):1925-33. PubMed ID: 3262644
[TBL] [Abstract][Full Text] [Related]
33. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
[TBL] [Abstract][Full Text] [Related]
34. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines.
Hemler ME; Sanchez-Madrid F; Flotte TJ; Krensky AM; Burakoff SJ; Bhan AK; Springer TA; Strominger JL
J Immunol; 1984 Jun; 132(6):3011-8. PubMed ID: 6327814
[TBL] [Abstract][Full Text] [Related]
35. B7, a B-cell-restricted antigen that identifies preactivated B cells.
Freedman AS; Freeman G; Horowitz JC; Daley J; Nadler LM
J Immunol; 1987 Nov; 139(10):3260-7. PubMed ID: 3500211
[TBL] [Abstract][Full Text] [Related]
36. Lymphoid cells, small cell lung cancer cells and epithelial cells share a membrane determinant which effects cell proliferation.
Armitage RJ; Kardamakis D; Goff LK; Beverley PC
Anticancer Res; 1989; 9(6):1825-33. PubMed ID: 2483307
[TBL] [Abstract][Full Text] [Related]
37. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
39. Human T cell lines differing in phenotype and specificity are reactive with the same anti-idiotypic antibody.
Borst J; Boylston AW; de Vries JE; Spits H
J Immunol; 1986 Jan; 136(2):601-8. PubMed ID: 2416817
[TBL] [Abstract][Full Text] [Related]
40. Murine T lymphoma cells express a novel membrane-associated antigen with unique features.
Takei F
J Immunol; 1987 Jul; 139(2):649-54. PubMed ID: 3496386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
